help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on April 3, 2007
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-0326
A more recent version of this article appeared on June 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
92/6/2115    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boi, F.
Right arrow Articles by Mariotti, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boi, F.
Right arrow Articles by Mariotti, S.
Related Collections
Right arrow Thyroid
Right arrow Endocrine Oncology

Submitted on February 12, 2007
Accepted on March 27, 2007

CALCITONIN MEASUREMENT IN WASH-OUT FLUID FROM FINE NEEDLE ASPIRATION OF NECK MASSES IN PATIENTS WITH PRIMARY AND METASTATIC MEDULLARY THYROID CARCINOMA

Francesco Boi, Ivan Maurelli, Giovanni Pinna, Francesca Atzeni, Mario Piga, Maria Letizia Lai, and Stefano Mariotti*

Endocrinology, Nuclear Medicine, Department of Medical Sciences "M. Aresu", Department of Cytomorphology San Giovanni di Dio Hospital, University of Cagliari, Cagliari, Italy

* To whom correspondence should be addressed. E-mail: mariotti{at}pacs.unica.it.

Objective: To evaluate the usefulness of calcitonin (CT) assay in fine needle aspiration biopsy (CT-FNAB) wash-out fluid alone or combined to cytology in the pre-surgical study of medullary thyroid carcinoma (MTC) patients with thyroid nodules and of suspicious neck MTC recurrences/metastases.

Subjects and methods: Thirthy-six ultrasound (US)-guided FNAB were performed in neck masses from 23 patients with borderline or high basal and pentagastrin (PG) stimulated serum CT. Cytology and CT-FNAB were performed on a total of 18 thyroid nodules (TN) and 3 neck lymph nodes (LN) from 12 patients examined before thyroidectomy and on 6 suspicious local recurrences (LR) and 9 LN from 9 totally thyroidectomized MTC patients. On the basis of CT-FNAB values found in 15 non-MTC lesions, CT-FNAB > 36 pg/ml was considered as indicative of MTC.

Results: All the 21 positive CT-FNAB lesions (10 TN, 6 LN and 5 LR), 13 with positive cytology, were confirmed as MTC at histology. Among the 15 negative CT-FNAB suspicious masses (8 TN, 6 LN and 1 LR) 5 displayed a benign lesion at histology. The remaining 10 cases, all with benign cytology, were not operated and no evidence of MTC has been detected at follow-up. CT-FNAB reached 100% of sensitivity and specificity for MTC, while cytology displayed 61.9% of sensitivity and 80% of specificity.

Conclusions: US-guided CT-FNAB resulted the best tool to identify primary MTC and local recurrences/node metastases in MTC operated subjects. This may have important implications in the management of MTC.


Key words: medullary thyroid cancer • thyroid nodule • calcitonin • fine-needle aspiration biopsy




This article has been cited by other articles:


Home page
The OncologistHome page
R. S. Sippel, M. Kunnimalaiyaan, and H. Chen
Current Management of Medullary Thyroid Cancer
Oncologist, May 1, 2008; 13(5): 539 - 547.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society